EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
The European Association of Hospital Pharmacists (EAHP) released its 2022 Annual Report which summarises the Association’s achievements in the past year. The report shares information about EAHP’s educational programme, projects – such as the European Statements of Hospital Pharmacy and the EAHP-ESCP Oath to Society – and advocacy work. Many activities centred around the changing roles of pharmacists.
In 2022, EAHP had several Special Interest Groups (SIGs) run in parallel focused on medication errors, hazardous medicinal products, prefilled syringes, automation, gene therapy and eliminating avoidable harm. EAHP’s SIGs gather and evaluate the evidence in specific, innovative and novel fields of hospital pharmacy practice with the aim to address patient needs and to advance the profession. Other milestones mentioned in the Annual Report, include the Association’s COVID-19 Report, the conceptual the framework of patient prioritisation and definition of pharmaceutical acuity and the EAHP Report on the future potential of electronic product information (ePI).
Reach EAHP’s 2022 Annual Report HERE
Earlier this month, the European Medicines Agency (EMA) released a new guidance document outlining “Good practices for industry for the prevention of human medicinal product shortages” focused on different actors along the supply chain.
The guidance was developed by the Heads of Medicines Agencies (HMA) / EMA Task Force on the Availability of Authorised Medicines for Human and Veterinary Use, following an analysis of the causes of shortages and regulators’ first-hand experience in coordinating the management of shortages. Industry associations were consulted during its establishment. It provides recommendations for marketing authorisation holders, wholesalers, distributors and manufacturers to minimise the occurrence of medicine shortages and their impact. Recommendations listed in the guidance include:
Read the guidance HERE
The European Centre for Disease Prevention and Control (ECDC) issued a Surveillance Report focused on the Increase in Escherichia coli isolates carrying blaNDM-5 in the European Union/European Economic Area 2012 – 2022 that are spreading rapidly and on a large geographical scale.
Researchers analysed 874 E. coli isolates carrying blaNDM-5, from 13 EU/EEA countries. Despite limited completeness of data, nearly 85% of the isolates with available information on travel and/or hospitalisation were linked to countries outside of the EU/EEA, mainly in Africa and Asia. The report emphasizes that based on the growing number of E. coli strains carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics are often used as the last resort to treat serious E. coli infections. This is an alarming trend that could also impact countries of EU and the European Economic Area (EEA) since as noted in the report travel-related acquisition may still be the most likely origin of these isolates.
Read the report HERE
The European Week Against Cancer takes place every year between 25 and 31 May to raise awareness about cancer prevention, access to treatment and support for patients and people with a history of cancer.
During this year’s edition, the European Commission is focusing on raising awareness about EU4Health-funded cancer projects, which contribute to the aims of Europe’s Beating Cancer Plan. To this end, a webinar was hosted on the first day of European Week Against Cancer to showcase selected projects that receive funding via the EU4Health programme. EAHP is contributing via a social media campaign outlining the role of hospital pharmacists.
Europe’s Beating Cancer Plan is a political commitment to turn the tide on cancer and together with the EU Mission on Cancer has already put several measures into action. The four key action areas touch on prevention, early detection of cancer, diagnosis and treatment as well as improving the quality of life of cancer patients and survivors.
Learn more about the EU4Health-funded cancer projects HERE
Find more information on Europe’s Beating Cancer Plan HERE
WHO/Europe recently shared information on the positive impact of one of its communication-focused training modules for proactively addressing questions and concerns raised by patients and the public.
The report analysis the impact of the training module “Communicating with patients about COVID-19 vaccination” and its implementation in Greece. The evaluation was conducted online, which allowed 118 health workers from all over Greece to participate. Data for the evaluation were generated using a combination of quantitative and qualitative methods: pre- and post-training questionnaires, observations of how participants used their communication skills in simulated consultations, in-depth interviews, and focus-group discussions.
Read the report HERE
A recent online first article published in the European Journal of Hospital Pharmacy (EJHP) looks at the economic impact of clinical trial drug cost savings in a French academic institution from the perspectives of both the French Health Insurance (FHI) and hospitals. Researchers carried out a retrospective, observational, cost-saving analysis on all the clinical trials initiated in the university hospital between 2015 and 2020. With ever-changing prices and new innovative treatments, such cost avoidance must be regularly evaluated. The study provided objective evidence that clinical trials could achieve potential cost savings for the FHI and hospitals, in addition to the potential benefit to patients of having access to innovative investigational medicinal products.
Read the article HERE
Drug Information Centre Survey
The University Hospitals of Leuven (UZ Leuven) is developing a drug information centre (DIC) to expand their current services. A DIC is defined as a centre that provides technical and scientific information about drugs in an objective and timely manner to ensure the safe and effective use of therapeutic and diagnostic pharmaceuticals. To support the development of the DIC in UZ Leuven a survey has been designed aiming to collect information about the operations, service characteristics and governance of DIC’s already operating in Europe. This survey will take approximately 3-20 minutes to complete depending on the path which is followed.
Contribute to the survey via the following LINK
Bedside clinical pharmacists in Europe
In this research, organized by the Semmelweis University, Hungary the position of bedside clinical pharmacists in hospitals will be assessed to gain insight into the routine practices and the provided clinical pharmacy services. The researchers would like to hear your opinion based on your experiences, so there are no correct or incorrect answers. It takes about 15 minutes to complete the questionnaire.
Contribute to the survey via the following LINK
European Paediatric Formulary: Clonidine hydrochloride oral solution
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has just released Issue 6 of Pharmeuropa PaedForm, in which the draft text for Clonidine Hydrochloride 10 micrograms/mL Oral Solution is published for public consultation with a view to its later inclusion in the European Paediatric Formulary. The deadline for comments is 30 June 2023. This is the seventh monograph elaborated on by the PaedF Working Party. EDQM welcomes all comments on this new monograph from users and interested parties.
Learn more about this consultation HERE
